Squarepoint’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,728
Closed -$175K 3993
2023
Q3
$175K Buy
4,728
+1,825
+63% +$81.2K ﹤0.01% 3453
2023
Q2
$117K Sell
2,903
-1,368
-32% -$77.4K ﹤0.01% 3332
2023
Q1
$310K Buy
4,271
+2,641
+162% +$256K ﹤0.01% 2552
2022
Q4
$134K Sell
1,630
-6,526
-80% -$680K ﹤0.01% 2905
2022
Q3
$771K Buy
+8,156
New +$916K ﹤0.01% 1939
2021
Q2
Sell
-4,754
Closed -$1.71M 3212
2021
Q1
$1.71M Buy
4,754
+2,095
+79% +$926K 0.01% 1154
2020
Q4
$1.3M Buy
2,659
+442
+20% +$204K 0.01% 1169
2020
Q3
$718K Sell
2,217
-3,384
-60% -$1.15M 0.01% 1192
2020
Q2
$2.04M Buy
5,601
+4,034
+257% +$1.02M 0.03% 623
2020
Q1
$333K Buy
1,567
+856
+120% +$272K 0.01% 1252
2019
Q4
$293K Sell
711
-286
-29% -$98.6K ﹤0.01% 2050
2019
Q3
$352K Buy
+997
New +$372K ﹤0.01% 1804
2019
Q2
Sell
-1,159
Closed -$1.15M 2360
2019
Q1
$1.15M Buy
1,159
+501
+76% +$465K 0.01% 1029
2018
Q4
$571K Sell
658
-294
-31% -$273K 0.01% 1180
2018
Q3
$984K Sell
952
-464
-33% -$454K 0.01% 994
2018
Q2
$1.3M Buy
1,416
+968
+216% +$1.04M 0.02% 791
2018
Q1
$437K Sell
448
-370
-45% -$337K 0.01% 1139
2017
Q4
$370K Buy
+818
New +$302K 0.01% 1374
2017
Q1
Sell
-407
Closed -$145K 1519
2016
Q4
$145K Buy
+407
New +$172K 0.01% 1548
2016
Q2
Sell
-648
Closed -$308K 1094
2016
Q1
$308K Buy
648
+336
+108% +$151K 0.02% 813
2015
Q4
$206K Buy
+312
New +$236K 0.02% 981

Other funds holding ATRA